On The Fast Track: The FDA And Drug Approvals

On The Fast Track: The FDA And Drug Approvals

We explore the new push at the Food and Drug Administration to fast-track some medications, and find out how scientists and safety experts are weighing the risks and benefits.

In the past year, the Food and Drug Administration approved 35 new medicines -- a near-record for the last decade. After years of slow but steady drug approvals, the FDA is considering speedier review and acceptance of innovative medicines, especially obesity treatments, antibiotics and drugs to fight infectious diseases. But scientists warn expedited approvals come with enhanced risks. We explore the push for new medications and the struggle to balance risks and benefits.


Thomas J. Moore

Senior Scientist, Drug Safety and Policy, The Institute for Safe Medication Practices

Dr. Robert Temple

Deputy Director for Clinical Science, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Allan Coukell

Director, Medical Programs, Pew Health Group

Related Links

Please familiarize yourself with our Code of Conduct and Terms of Use before posting your comments.

The Kojo Nnamdi Show is produced by member-supported WAMU 88.5 in Washington DC.